Correction regarding the publication date of coming interim report
Previously communicated publication date for Interim Report 1 2019/20 was incorrect. The correct publication date is September 23, 2019 and nothing else.
Previously communicated publication date for Interim Report 1 2019/20 was incorrect. The correct publication date is September 23, 2019 and nothing else.
PHI announces today that the Company has been granted a patent concerning synthetic antibodies in Japan.
PHI and Wake Forest Institute for Regenerative Medicine recently signed a letter of intent outlining a biomanufacturing initiative to make indispensable imaging techniques available for regenerative medicine and large-scale production of cell therapies and organs.
Subscription commitments corresponding to approximately 4 % of the initial rights issue (2.9 million SEK) have been signed with members of the company’s board, the company’s CEO and with owners.